Edition:
United Kingdom

Profile: Thyrocare Technologies Ltd (THYO.NS)

THYO.NS on National Stock Exchange of India

460.15INR
10:59am BST
Change (% chg)

Rs-2.85 (-0.62%)
Prev Close
Rs463.00
Open
Rs460.10
Day's High
Rs463.75
Day's Low
Rs458.00
Volume
3,355
Avg. Vol
28,880
52-wk High
Rs694.80
52-wk Low
Rs425.05

Thyrocare Technologies Limited is an India-based healthcare service provider. The Company operates with a centralized processing laboratory (CPL) in Mumbai, India for esoteric tests, and regional processing laboratory in metro cities of India and other parts of Asia. The Company offers technologies, including Chemiluminescence Immunoassay (CLIA), Enzyme Linked Immunosorbent Assay (ELISA), High Performance Liquid Chromatography (HPLC), Capillary Electrophoresis (CE), Ion Selective Electrode (ISE), Fluorescence Flow Cytometry, Nephelometry, Photometry, Liquid Chromatography Mass Spectrometry (LC-MS), Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) and Cytogenetics. The Company offers cancer diagnosis and water testing through its brands Nueclear and Whaters, respectively. The Company tests cover varied age groups from offerings for prenatal screening, to screening for hormonal imbalance, nutritional deficiencies and tracking lifestyle disorders.

Company Address

Thyrocare Technologies Ltd

D-37/1, Midc, Turbhe, Opp., Sand
NAVI MUMBAI     400703
P: +9122.41252525
F: +9122.27682409

Company Web Links